ФАРМА КОНСУЛТ БЪЛГАРИЯ ООД
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 2
- Amount won alone
- €279,960 excl. VAT
- Period
- 10 September 2026 – 23 October 2026
Its main clients
Where and what
Supplies · 2
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 9 December 2026 re-tender around October 2026 |
Доставка на лекарствен продукт по Наредба 10 от 17.11.2011 г. - Burosumab
УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ "АЛЕКСАНДРОВСКА" ЕАД |
ФАРМА КОНСУЛТ БЪЛГАРИЯ ООД 3 bids received |
€152,160 |
| 21 January 2027 re-tender around October 2026 |
Доставка на лекарствен продукт по Наредба 10 от 17.11.2011 г. - Burosumab/ CRYSVITA- 20 mg/ml-1 ml solution for inj., 30 mg/ml-1 ml solution for inj.
УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ "АЛЕКСАНДРОВСКА" ЕАД |
ФАРМА КОНСУЛТ БЪЛГАРИЯ ООД 5 bids received |
€127,800 |
Contracts won
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.